<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="correction" dtd-version="2.3" xml:lang="EN">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Endocrinol.</journal-id>
<journal-title>Frontiers in Endocrinology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Endocrinol.</abbrev-journal-title>
<issn pub-type="epub">1664-2392</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fendo.2023.1301830</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Endocrinology</subject>
<subj-group>
<subject>Erratum</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Erratum: The role of GABA in islet function</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<collab>Frontiers Production Office</collab>
<xref ref-type="author-notes" rid="fn001"><sup>*</sup></xref>
<uri xlink:href="https://loop.frontiersin.org/people/20170"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
</contrib>
</contrib-group>
<aff id="aff1"><institution>Frontiers Media SA</institution>, <addr-line>Lausanne</addr-line>, <country>Switzerland</country></aff>
<author-notes>
<fn fn-type="edited-by">
<p>Approved by: Frontiers Editorial Office, Frontiers Media SA, Switzerland</p>
</fn>
<fn fn-type="corresp" id="fn001">
<p>*Correspondence: Frontiers Production Office, <email xlink:href="mailto:production.office@frontiersin.org">production.office@frontiersin.org</email>
</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>02</day>
<month>10</month>
<year>2023</year>
</pub-date>
<pub-date pub-type="collection">
<year>2023</year>
</pub-date>
<volume>14</volume>
<elocation-id>1301830</elocation-id>
<history>
<date date-type="received">
<day>25</day>
<month>09</month>
<year>2023</year>
</date>
<date date-type="accepted">
<day>25</day>
<month>09</month>
<year>2023</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2023 Frontiers Production Office</copyright-statement>
<copyright-year>2023</copyright-year>
<copyright-holder>Frontiers Production Office</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
</license>
</permissions>
<related-article id="RA1" related-article-type="corrected-article" xlink:href="10.3389/fendo.2022.972115" ext-link-type="doi">An Erratum on <article-title>The role of GABA in islet function</article-title> by Hagan DW, Ferreira SM, Santos GJ and Phelps EA (2022) <italic>Front. Endocrinol</italic>. 13:972115. doi:&#xa0;<object-id>10.3389/fendo.2022.972115</object-id>
</related-article>
<kwd-group>
<kwd>&#x3b3;-Aminobutyric acid (GABA)</kwd>
<kwd>islet</kwd>
<kwd>pancreas</kwd>
<kwd>signaling</kwd>
<kwd>receptor</kwd>
<kwd>insulin</kwd>
<kwd>beta cell</kwd>
</kwd-group>
<counts>
<fig-count count="1"/>
<table-count count="0"/>
<equation-count count="0"/>
<ref-count count="0"/>
<page-count count="2"/>
<word-count count="210"/>
</counts>
<custom-meta-wrap>
<custom-meta>
<meta-name>section-in-acceptance</meta-name>
<meta-value>Diabetes: Molecular Mechanisms</meta-value>
</custom-meta>
</custom-meta-wrap>
</article-meta>
</front>
<body>
<p>Due to a production error, there was a mistake in the penultimate sentence of the caption of <xref ref-type="fig" rid="f1"><bold>Figure&#xa0;1</bold></xref>. The subscript &#x201c;<sub>A</sub>&#x201d; in &#x201c;GABA<sub>A</sub>R&#x201d; should have been &#x201c;<sub>B</sub>&#x201d;. The corrected caption appears below, along with <xref ref-type="fig" rid="f1"><bold>Figure&#xa0;1</bold></xref>.</p>
<fig id="f1" position="float">
<label>Figure&#xa0;1</label>
<caption>
<p>GABA in the whole islet. Application of exogenous GABA has various effects on the islet including stimulation of beta cell regeneration, inhibition of insulin secretion, and negative regulation of immune cells. Endogenous GABA levels are highly enriched in the islet, as high as in the brain, and GABA is synthesized in and secreted from the beta cells. Immunofluorescence image depicts a human islet. GABA is secreted via multiple pathways that are both regulated and unregulated by glucose and with pulsatile, tonic, or phasic dynamics. Once secreted, GABA acts <italic>via</italic> GABA<sub>A</sub>R ligand-gated chloride channels and GABA<sub>A</sub>R inhibitory G protein coupled receptors. Set by the chloride equilibrium potential, in beta cells GABA<sub>A</sub>R signaling can be excitatory in low glucose and inhibitory in high glucose, while in alpha cells GABA<sub>A</sub>R signaling is inhibitory. GABA<sub>B</sub>R signaling is also inhibitory but may only be active in mouse and not human beta cells under typical physiological conditions. Created with <uri xlink:href="https://www.biorender.com">BioRender.com</uri>.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fendo-14-1301830-g001.tif"/>
</fig>
<p>The publisher apologizes for this mistake. The original version of this article has been updated.</p>
</body>
</article>
